Find where to buy products from UK suppliers, including: distributors, industrial manufacturers, wholesalers, raw ingredients, bulk supplies and finished goods for sale.
Search for products or services, then visit the suppliers website for prices, SDS or more information. You can also view suppliers in Australia, NZ or the USA.
| Product | Description | |
|---|---|---|
| abemaciclib mesylate | Abemaciclib mesylate is a CDK inhibitor with selectivity for CDK4 and CDK6. It was approved for the treatment of advanced or metastatic breast cancers. Uses: The treatment of advanced or metastatic breast cancers. Group: Pharmaceutical. Alternative Names: Verzenio; LY2835219; LY 2835219; LY-2835219; UNII-KKT462Q807; Abemaciclib methanesulfonate; N-(5-((4-ethylpiperazin-1-yl)methyl)pyridin-2-yl)-5-fluoro-4-(4-fluoro-1-isopropyl-2-methyl-1H-benzo[d]imidazol-6-yl)pyrimidin-2-amine methanesulfonate. CAS No. 1231930-82-7. Pack Sizes: 1 g. Product ID: B2693-463381. Molecular formula: C28H36F2N8O3S. Mole weight: 602.706. Custom synthesis is available. Send your inquiries for more information. |  London |
| Bromocriptine Mesylate | Bromocriptine mesylate is the mesylate salt of Bromocriptine. It is a dopamine receptor agonist. It is a derivative of the ergotoxin group of ergot alkaloids. Uses: Antiparkinson agents. Group: Pharmaceutical. Alternative Names: 2-Bromo α-Ergocryptine Mesylate; (5'α)-2-Bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)ergotaman-3',6',18-trione Methanesulfonate; 2-Bromoergocryptine; Bagren; CB 154; Parlodel; Pravidel. CAS No. 22260-51-1. Pack Sizes: 500 mg. Product ID: B2693-463773. Molecular formula: C33H44BrN5O8S. Mole weight: 750.72. Custom synthesis is available. Send your inquiries for more information. | London |
| Clomesone | Clomesone is a chloroethylating agent that induces the formation of cross-links between DNA strands in some cell lines and has shown antitumor activity in some animal models. It is a drug commonly used to treat female infertility and works by blocking the action of estrogen in the brain. It has been shown to be effective in inducing ovulation in women with polycystic ovary syndrome and other infertility conditions. Group: Pharmaceutical. Alternative Names: Methanesulfonic acid, 1-(methylsulfonyl)-, 2-chloroethyl ester; 2-Chloroethyl 1-(methylsulfonyl)methanesulfonate; Methanesulfonic acid, (methylsulfonyl)-, 2-chloroethyl ester; 2-Chloroethyl methanesulfonylmethanesulfonate; Chlorethyl SOSO; NSC 338947. CAS No. 88343-72-0. Pack Sizes: 1mg;1g;10g. Product ID: 88343-72-0. Molecular formula: C4H9ClO5S2. Mole weight: 236.7. Custom synthesis is available. Send your inquiries for more information. | London |
| Dabigatran etexilate mesylate | Dabigatran etexilate mesylate is the orally active prodrug of dabigatran. It is a reversible and selective, direct thrombin inhibitor (DTI). Group: Pharmaceutical. Alternative Names: Ethyl 3-(((2-(((4-(((hexyloxy)carbonyl)carbamimidoyl)phenyl)amino)methyl)-1-methyl-1h-benzimidazol-5-yl)carbonyl)(pyridin-2-yl)amino)propanoate, methanesulfonate; Dabigatran etexilate mesylate; BIBR 1048MS; BIBR1048MS; BIBR-1048MS; BIBR 1048; BIBR1048; BIBR-1048; band name: Pradaxa. CAS No. 872728-81-9. Pack Sizes: 2 g. Product ID: B0084-461975. Molecular formula: C35H45N7O8S. Mole weight: 723.84. Custom synthesis is available. Send your inquiries for more information. | London |
| Eribulin Mesylate | Eribulin Mesylate is an antitumor drug that can be used to treat patients with metastatic breast cancer. It inhibits the proliferation of cancer cells by binding tubulin and microtubules. Eribulin Mesylate can inhibit experimental metastasis of breast cancer cells by reversing phenotype from epithelial-mesenchymal transition (EMT) to mesenchymal-epithelial transition (MET) states. Uses: The treatmnet of breast cancer. Group: Pharmaceutical. Alternative Names: 11,15:18,21:24,28-Triepoxy-7,9-ethano-12,15-methano-9H,15H-furo[3,2-i]furo[2',3':5,6]pyrano[4,3-b][1,4]dioxacyclopentacosin-5(4H)-one, 2-[(2S)-3-amino-2-hydroxypropyl]hexacosahydro-3-methoxy-26-methyl-20,27-bis(methylene)-, (2R,3R,3aS,7R,8aS,9S,10aR,11S,12R,13aR,13bS,15S,18S,21S,24S,26R,28R,29aS)-, methanesulfonate (1:1); 11,15:18,21:24,28-Triepoxy-7,9-ethano-12,15-methano-9H,15H-furo[3,2-i]furo[2',3':5,6]pyrano[4,3-b][1,4]dioxacyclopentacosin-5(4H)-one, 2-[(2S)-3-amino-2-hydroxypropyl]hexacosahydro-3-methoxy-26-methyl-20,27-bis(methylene)-, (2R,3R,3aS,7R,8aS,9S,10aR,11S,12R,13aR,13bS,15S,18S,21S,24S,26R,28R,29aS)-, methanesulfonate (salt); E 7389 methanesulfonate; Halaven; Eribulin monomethanesulfonate. CAS No. 441045-17-6. Pack Sizes: 1 mg. Product ID: BADC-01399. Molecular formula: C41H63NO14S. Mole weight: 826.01. Custom synthesis is available. Send your inquiries for more information. | London |
| Paroxetine Mesylate | An impurity of Paroxetine which is a selective serotonin reuptake inhibitor. Group: Pharmaceutical. Alternative Names: Paroxetine Mesylate; 217797-14-3; Paroxetine Mesilate; POT.mes; Paroxetine methanesulfonate; Brisdelle; Mesafem; Pexeva; Paroxetine methanesulphonate; LDMP; PO-T.MES; M711N184JE; (3S,4R)-3-((Benzo[d][1,3]dioxol-5-yloxy)methyl)-4-(4-fluorophenyl)piperidine methanesulfonate; Paroxetine Mesylate [USAN]; UNII-M711N184JE; Paroxetine mesylate (USAN);(-)-(3S,4R)-4-(p-Fluorophenyl)-3-((3,4-(methylenedioxy)phenoxy)methyl)piperidine Mesylate; (3S,4R)-3-((Benzo[d][1,3]dioxol-5-yloxy)methyl)-4-(4-fluorophenyl)piperidinemethanesulfonate; (3S,4R)-3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidin-1-ium; methanesulfonate; Piperidine, 3-((1,3-benzodioxol-5-yloxy)methyl)-4-(4-fluorophenyl)-,(3S,4R)-, Methanesulfonate. CAS No. 217797-14-3. Pack Sizes: 100 mg. Product ID: B2694-478603. Molecular formula: C19H20FNO3.CH4O3S. Mole weight: 425.48. Custom synthesis is available. Send your inquiries for more information. | London |
| Rucaparib monocamsylate | Rucaparib camsylate is an inhibitor of poly (ADP-ribose) polymerase (PARP) enzymes, which work in DNA repair process. It was approved for the treatment of ovarian cancer, and Rubraca is proved to be a monotherapy for the patients deleterious BRCA mutation associated advanced ovarian cancer who were treated with two or more chemotherapies. Group: Pharmaceutical. Alternative Names: Rucaparib camsylate; Bicyclo[2.2.1]heptane-1-methanesulfonic acid, 7,7-dimethyl-2-oxo-, (1S,4R)-, compd. with 8-fluoro-1,3,4,5-tetrahydro-2-[4-[(methylamino)methyl]phenyl]-6H-pyrrolo[4,3,2-ef][2]benzazepin-6-one (1:1); 8-fluoro-5-(4-((methylamino)methyl)phenyl)-2,3,4,6-tetrahydro-1H-azepino[5,4,3-cd]indol-1-one ((1S,4R)-7,7-dimethyl-2-oxobicyclo[2.2.1]heptan-1-yl)methanesulfonate (1:1); 8-Fluoro-1,3,4,5-tetrahydro-2-[4-[(methylamino)methyl]phenyl]-6H-pyrrolo[4,3,2,ef][2]benzazepin-6-one (1S,4R)-7,7-dimethyl-2-oxobicyclo[2.2.1]heptane-1-methanesulfonic acid (1:1). CAS No. 1859053-21-6. Pack Sizes: 100 mg. Product ID: B0084-007117. Molecular formula: C29H34FN3O5S. Mole weight: 555.66. Custom synthesis is available. Send your inquiries for more information. | London |
| 2-Bromo-1-[4-(methylsulfonyl)phenyl]-1-ethanone | 2-Bromo-1-[4-(methylsulfonyl)phenyl]-1-ethanone possesses significant utility within the biomedical field, particularly in the realm of disease therapeutics such as cancer and inflammation. Furthermore, its application extends to the innovative creation of targeted pharmaceutical agents tailored to distinct molecular routes, emphasizing its paramount significance in advancing medical treatments. Group: Pharmaceutical. Alternative Names: 50413-24-62-Bromo-1-[4-(methylsulfonyl)phenyl]-1-ethanone2-bromo-1-(4-(methylsulfonyl)phenyl)ethanone2-bromo-1-(4-methylsulfonylphenyl)ethanone2-Bromo-1-(4-methanesulfonyl-phenyl)-ethanone. CAS No. 50413-24-6. Pack Sizes: 1mg;1g;10g. Product ID: 50413-24-6. Molecular formula: C9H9BrO3S. Mole weight: 277.13. Custom synthesis is available. Send your inquiries for more information. | London |
| ABT-072 | ABT-072 is a potent and orally active non-nucleoside HCV NS5B polymerase inhibitor with EC50s of 1 nM and 0.3 nM for HCV GT1a and HCV GT1b, respectively. Group: Pharmaceutical. Alternative Names: (E)-N-(4-(3-(tert-Butyl)-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-2-methoxystyryl)phenyl)methanesulfonamide; Methanesulfonamide, N-[4-[(1E)-2-[5-(3,4-dihydro-2,4-dioxo-1(2H)-pyrimidinyl)-3-(1,1-dimethylethyl)-2-methoxyphenyl]ethenyl]phenyl]-; N-(4-{(E)-2-[5-(2,4-Dioxo-3,4-dihydro-1(2H)-pyrimidinyl)-2-methoxy-3-(2-methyl-2-propanyl)phenyl]vinyl}phenyl)methanesulfonamide. CAS No. 1132936-00-5. Pack Sizes: 1mg;1g;10g. Product ID: 1132936-00-5. Molecular formula: C24H27N3O5S. Mole weight: 469.55. Custom synthesis is available. Send your inquiries for more information. | London |
| Apilimod mesylate | The mesylate salt form of Apilimod. Apilimod is a potent and orally-available inhibitor of the cytokines interleukin-12 (IL-12) and interleukin-23 (IL-23) with the potential to treat certain autoimmune and inflammatory diseases by inhibition of IL-12 and IL-23 production. Group: Pharmaceutical. Alternative Names: methanesulfonic acid N-[(E)-(3-methylphenyl)methylideneamino]-6-morpholin-4-yl-2-(2-pyridin-2-ylethoxy)pyrimidin-4-amine. CAS No. 870087-36-8. Pack Sizes: 50 mg. Product ID: B2693-054451. Molecular formula: C23H26N6O2.2CH4O3S. Mole weight: 610.7. Custom synthesis is available. Send your inquiries for more information. | London |
| Deoxysotalol hydrochloride | An impurity of Sotalol. Sotalol is a non-selective competitive beta-adrenergic receptor blocker that also exhibits Class III antiarrhythmic properties. Group: Pharmaceutical. Alternative Names: Sotalol EP Impurity A Hydrochloride; Sotalol USP Related Comopound C; Deshydroxy Sotalol Hydrochloride; N-(4-(2-((1-Methylethyl)amino)ethyl)phenyl)methanesulfonamide monohydrochloride. CAS No. 16974-44-0. Pack Sizes: 50 mg. Product ID: B1370-275368. Molecular formula: C12H21ClN2O2S. Mole weight: 292.83. Custom synthesis is available. Send your inquiries for more information. | London |
| E-4031 | E-4031, a benzenesulfonamide derivative, could be used as a Class III antiarrhythmic agent due to its effect of blocking the ERG potassium channels. Uses: E-4031 could be used as a class iii antiarrhythmic agent due to its effect of blocking the erg potassium channels. Group: Pharmaceutical. Alternative Names: E-4031; E 4031; E4031; 113559-13-0;CHEMBL536480;E-4031dihydrochloride;E-4031;1-(2-(6-Methyl-2-pyridyl)ethyl)-4-(4-methylsulfonylaminobenzoyl)piperidinedihydrochloride;N-[4-[[1-[2-(6-methyl-2-pyridinyl)ethyl]-4-piperidinyl]carbonyl]phenyl]methanesulfonamidedihydrochloride. CAS No. 113559-13-0. Pack Sizes: 25 mg. Product ID: B2693-338550. Molecular formula: C21H29Cl2N3O3S. Mole weight: 474.44. Custom synthesis is available. Send your inquiries for more information. | London |
| Encorafenib | Encorafenib, also known as LGX-818, is an orally available Raf kinase inhibitor with potential antineoplastic activity. LGX818 specifically inhibits Raf kinase, a serine/threonine enzyme in the RAF/mitogen-activated protein kinase kinase (MEK)/extracellular signal-related kinase (ERK) signaling pathway. By inhibiting the activation of the RAF/MEK/ERK signaling pathway, the administration of LGX818 may result in a decrease in proliferation of tumor cells. The Raf mutation BRAF V600E is frequently upregulated in a variety of human tumors and results in the constitutive activation of the RAF/MEK/ERK signaling pathway that regulates cellular proliferation and survival. Group: Pharmaceutical. Alternative Names: LGX818; LGX-818; LGX 818; Methyl N-[(2S)-1-[[4-[3-[5-chloro-2-fluoro-3-(methanesulfonamido)phenyl]-1-propan-2-ylpyrazol-4-yl]pyrimidin-2-yl]amino]propan-2-yl]carbamate. CAS No. 1269440-17-6. Pack Sizes: 150 mg. Product ID: B0084-462563. Molecular formula: C22H27ClFN7O4S. Mole weight: 540.011. Custom synthesis is available. Send your inquiries for more information. | London |
| Lapatinib-[13C,d7] | Lapatinib-[13C,d7] is the labelled analogue of Lapatinib, a reversible dual inhibitor of ErbB1 and ErbB2 tyrosine kinases. It can be used for the treatment of breast cancer and other solid tumours. Group: Pharmaceutical. Alternative Names: Lapatinib-13C,D7; Lapatinib Ditosylate-13C,d7; Tykerb-13C,d7; GW 572016-13C,d7; Tyverb-13C,d7; N-{3-chloro-4-[(3-fluorophenyl)methoxy]phenyl}-6-[5-({[2-(13C,D3)methanesulfonyl(D4)ethyl]amino}methyl)furan-2-yl]quinazolin-4-amine. CAS No. 1210608-87-9. Pack Sizes: 1 mg. Product ID: BLP-011601. Molecular formula: C28[13C]H19D7ClFN4O4S. Mole weight: 589.09. Custom synthesis is available. Send your inquiries for more information. | London |
| Methanesulfonamide | Methanesulfonamide is used in biological studies to predict binding affinity and binding mode of protein ligand complexes. Group: Pharmaceutical. Alternative Names: Methylsulfonamide; Methanesulphonamide; Methane sulfonamide. CAS No. 3144-09-0. Pack Sizes: 1 kg. Product ID: B1370-313027. Molecular formula: CH5NO2S. Mole weight: 95.12. Custom synthesis is available. Send your inquiries for more information. | London |
| N-Desmethyl Dofetilide | N-Desmethyldofetilide is a derivative of Dofetilide. Dofetilide is a selective potassium channel ((hERG)) blocker, used as a Class III antiarrhythmic drug. Group: Pharmaceutical. Alternative Names: Dofetilide USP Related Compound A; Dofetilide Impurity 1; Methanesulfonamide, N-[4-[2-[[2-[4-[(methylsulfonyl)amino]phenoxy]ethyl]amino]ethyl]phenyl]-; N-(4-(2-((4-(Methylsulfonamido)phenethyl)amino)ethoxy)phenyl)methanesulfonamide. CAS No. 176447-94-2. Pack Sizes: 50 mg. Product ID: B1370-165790. Molecular formula: C18H25N3O5S2. Mole weight: 427.54. Custom synthesis is available. Send your inquiries for more information. | London |
| Nimesulide Impurity E | An impurity of Nimesulide, which is a selective COX-7 inhibitor. Group: Pharmaceutical. Alternative Names: N-(Methylsulfonyl)-4-(desnitro) Nimesulide; N-(Methylsulfonyl)-N-(2-phenoxyphenyl)methanesulfonamide. CAS No. 905858-63-1. Pack Sizes: 10 mg. Product ID: B0159-478173. Molecular formula: C14H15NO5S2. Mole weight: 341.41. Custom synthesis is available. Send your inquiries for more information. | London |
| Nimesulide Impurity F | An impurity of Nimesulide, which is a selective COX-5 inhibitor. Group: Pharmaceutical. Alternative Names: N-Methylsulfonyl Nimesulide; N-(Methylsulfonyl)-N-(4-nitro-2-phenoxyphenyl)methanesulfonamide; N-(Methylsulfonyl)-4'-nitro-2'-phenoxymethanesulfonanilide. CAS No. 51765-72-1. Pack Sizes: 100 mg. Product ID: B0159-478172. Molecular formula: C14H14N2O7S2. Mole weight: 386.4. Custom synthesis is available. Send your inquiries for more information. | London |
| Obatoclax mesylate | Obatoclax mesylate is the mesylate salt of obatoclax, a synthetic small-molecule inhibitor of the bcl-2 family of proteins with potential pro-apoptotic and antineoplastic activities. Obatoclax binds to members of the Bcl-2 protein family, preventing the binding of these anti-apoptotic proteins to the pro-apoptotic proteins Bax and Bak and so promoting the activation of the apoptotic pathway in Bcl-2-overexpressing cells. The Bcl-2 family of proteins (bcl-2, bcl-xl, bcl-w, and Mcl-1) are overexpressed in a wide variety of cancers, including those of the lymphatic system, breast, lung, prostate, and colon. Group: Pharmaceutical. Alternative Names: (2E)-2-[(5Z)-5-[(3,5-dimethyl-1H-pyrrol-2-yl)methylidene]-4-methoxypyrrol-2-ylidene]indole methanesulfonic acid. CAS No. 803712-79-0. Pack Sizes: 500 mg. Product ID: B0084-135253. Molecular formula: C20H19N3O.CH4O3S. Mole weight: 413.492. Custom synthesis is available. Send your inquiries for more information. | London |
| Oclacitinib maleate | Oclacitinib maleate was the first selective Janus kinase (JAK) inhibitor to be developed for dogs. Oclacitinib is most potent at inhibiting JAK1 (IC50=10 nM). Group: Pharmaceutical. Alternative Names: Cyclohexanemethanesulfonamide, N-methyl-4-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-, trans-, (2Z)-2-butenedioate (1:x); Apoquel; Oclacitinib maleate (1:x); PF 03394197-11; trans-N-Methyl-4-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)cyclohexanemethanesulfonamide maleate (1:x); N-methyl-1-((1r,4r)-4-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)cyclohexyl)methanesulfonamide maleate. CAS No. 1208319-27-0. Pack Sizes: 10 g. Product ID: B1370-007675. Molecular formula: C15H23N5O2S.xC4H4O4. Mole weight: 337.44 (free base). Custom synthesis is available. Send your inquiries for more information. | London |
| Oclacitinib monomaleate | Oclacitinib, also called as PF-03394197, is a novel inhibitor of JAK family members (IC50 = 10 - 99 nM) and JAK1-dependent cytokines involved in allergy, inflammation, and pruritus (IC50 = 36 - 249 nM), without affecting a panel of 38 non-JAK kinases. It could reduce pruritus and associated inflammatory skin lesions in dogs with AD. Group: Pharmaceutical. Alternative Names: Cyclohexanemethanesulfonamide, N-methyl-4-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-, trans-, (2Z)-2-butenedioate (1:1); trans-N-Methyl-4-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)cyclohexanemethanesulfonamide maleate (1:1); N-methyl-1-((1r,4r)-4-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)cyclohexyl)methanesulfonamide monomaleate. CAS No. 1640292-55-2. Pack Sizes: 50 mg. Product ID: B2693-008142. Molecular formula: C15H23N5O2S.C4H4O4. Mole weight: 453.51. Custom synthesis is available. Send your inquiries for more information. | London |
| Presatovir | Presatovir is a viral fusion protein inhibitor with EC50 value of 0.43 nM. It can inhibit a broad range of respiratory syncytial virus clinical isolates by blocking the virus-cell fusion process. It can also inhibit pre- to post-fusion conformational changes of the respiratory syncytial virus fusion protein. Phase II clinical trials for the treatment of respiratory syncytial virus infections is ongoing. Group: Pharmaceutical. Alternative Names: N-(2-((S)-2-(5-((S)-3-aminopyrrolidin-1-yl)-6-methylpyrazolo[1,5-a]pyrimidin-2-yl)piperidine-1-carbonyl)-4-chlorophenyl)methanesulfonamide; GS-5806; GS5806; GS 5806. CAS No. 1353625-73-6. Pack Sizes: 5 mg. Product ID: B0084-475346. Molecular formula: C24H30ClN7O3S. Mole weight: 532.06. Custom synthesis is available. Send your inquiries for more information. | London |
| Pridopidine | Pridopidine, also known as ACR16, is a dopamine stabilizer used in the treatment of neurologic and psychiatric disorders. Uses: Dopamine d2 receptor antagonists; glutamate modulators; sigma-1 receptor agonists. Group: Pharmaceutical. Alternative Names: 4-[3-(Methylsulfonyl)phenyl]-1-propylpiperidine; ACR 16; ACR16; ACR-16; FR310826; FR-310826; FR 310826; 4-(3-Methanesulfonyl-phenyl)-1-propyl-piperidine. CAS No. 346688-38-8. Pack Sizes: 100 mg. Product ID: B2693-110584. Molecular formula: C15H23NO2S. Mole weight: 587.71. Custom synthesis is available. Send your inquiries for more information. | London |
| Rosuvastatin EP Impurity D | Rosuvastatin EP Impurity D is an impurity of Rosuvastatin, which is a statin medication used to prevent cardiovascular disease in those at high risk and treat abnormal lipids. Group: Pharmaceutical. Alternative Names: Rosuvastatin Calcium EP Impurity D; N-(4-(4-Fluorophenyl)-5-((E)-2-((2S,4R)-4-hydroxy-6-oxotetrahydro-2H-pyran-2-yl)vinyl)-6-isopropylpyrimidin-2-yl)-N-methylmethanesulfonamide; N-[4-(4-Fluorophenyl)-5-[(1E)-2-[(2S,4R)-4-hydroxy-6-oxooxan-2-yl]ethen-1-yl]-6-(propan-2-yl)pyrimidin-2-yl]-N-methylmethanesulfonamide; N-[4-(4-Fluorophenyl)-5-[(E)-2-[(2S,4R)-4-hydroxy-6-oxotetrahydro-2H-pyran-2-yl]ethenyl]-6-(1-methylethyl)-pyrimidin-2-yl]-N-methylmethanesulfonamide; Rosuvastatin Lactone; Methanesulfonamide, N-[4-(4-fluorophenyl)-6-(1-methylethyl)-5-[(1E)-2-[(2S,4R)-tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl]ethenyl]-2-pyrimidinyl]-N-methyl-; N-[4-(4-Fluorophenyl)-6-(1-methylethyl)-5-[(1E)-2-[(2S,4R)-tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl]ethenyl]-2-pyrimidinyl]-N-methylmethanesulfonamide; Rosuvastatin-5S-lactone. CAS No. 503610-43-3. Pack Sizes: 10 mg. Product ID: B0194-069823. Molecular formula: C22H26FN3O5S. Mole weight: 463.53. Custom synthesis is available. Send your inquiries for more information. | London |
| Sumatriptan succinate | Sumatriptan Succinate is a triptan sulfa drug containing a sulfonamide group for the treatment of migraine headaches. Uses: Vasoconstrictor agents. Group: Pharmaceutical. Alternative Names: Imigran; Imitrex; Sumitrex; Arcoiran; GR 43175; GR43175; GR-4317; 3-[2-(Dimethylamino)ethyl]-N-methyl-1H-indole-5-methanesulfonamide Succinate. CAS No. 103628-48-4. Pack Sizes: 1 g. Product ID: B1370-053376. Molecular formula: C18H27N3O6S. Mole weight: 413.49. Custom synthesis is available. Send your inquiries for more information. | London |
| Talabostat mesylate | Talabostat mesylate is the orally bioavailable mesylate salt of an amino boronic dipeptide with antineoplastic and hematopoiesis- stimulating activities. By cleaving N-terminal Xaa-Pro or Xaa-Ala residues, talabostat inhibits dipeptidyl peptidases, such as fibroblast activation protein (FAP), resulting in the stimulation of cytokine and chemokine production and specific T-cell immunity and T-cell- dependent activity. This agent may also stimulate the production of colony stimulating factors, such as granulocyte colony stimulating factor (G-CSF), resulting in the stimulation of hematopoiesis. Dipeptidyl peptidases are involved in the activation of polypeptide hormones and chemokines. Uses: For research used only. Group: Pharmaceutical. Alternative Names: (R)-1-((S)-2-amino-3-methylbutanoyl)pyrrolidin-2-ylboronic acid methanesulfonic acid (1:1); PT-100; PT100; PT 100; D05989; D-05989; D 05989; Val-boro-pro; Talabostat. CAS No. 150080-09-4. Pack Sizes: 20 mg. Product ID: B0084-084554. Molecular formula: C10H23BN2O6S. Mole weight: 310.17. Custom synthesis is available. Send your inquiries for more information. | London |
Our database is helping our users find suppliers everyday.
